Litcius/Paper detail

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

Petros Christopoulos, Klaus Kluck, Martina Kirchner, H Lüders, Julia Roeper, Roger-Fei Falkenstern-Ge, Marlen Szewczyk, Florian Sticht, Felix Carl Saalfeld, Claas Wesseler, Björn Hackanson, Sebastian Dintner, Martin Faehling, Jonas Kuon, Melanie Janning, Diego Kauffmann‐Guerrero, Daniel Kazdal, S Kurz, Florian Eichhorn, Farastuk Bozorgmehr, Rajiv Shah, Amanda Tufman, Martin Wermke, Sonja Loges, Wolfgang M. Brueckl, Christian Schulz, Daniel Misch, Nikolaj Frost, Jens Kollmeier, Martin Reck, Frank Griesinger, Christian Grohé, Jin‐Liern Hong, Huamao Mark Lin, Jan Budczies, Albrecht Stenzinger, Michael Thomas

2022European Journal of Cancer25 citationsDOI

Topics & Concepts

ChemoimmunotherapyMedicineLung cancerInternal medicineBevacizumabOncologyPemetrexedProgression-free survivalKRASCancerChemotherapyImmunotherapyCisplatinColorectal cancerLung Cancer Treatments and MutationsCancer-related Molecular PathwaysCancer Immunotherapy and Biomarkers